These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. Hebbel RP; Yamada O; Moldow CF; Jacob HS; White JG; Eaton JW J Clin Invest; 1980 Jan; 65(1):154-60. PubMed ID: 7350195 [TBL] [Abstract][Full Text] [Related]
3. Erythrocyte/endothelial interactions in the pathogenesis of sickle-cell disease: a "real logical" assessment. Hebbel RP; Eaton JW; Steinberg MH; White JG Blood Cells; 1982; 8(1):163-73. PubMed ID: 7115974 [TBL] [Abstract][Full Text] [Related]
4. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia. Bertles JF; Milner PF J Clin Invest; 1968 Aug; 47(8):1731-41. PubMed ID: 5666109 [TBL] [Abstract][Full Text] [Related]
5. Erythrocyte membrane abnormalities in sickle cell disease. Williamson P; Puchulu E; Westerman M; Schlegel RA Biotechnol Appl Biochem; 1990 Oct; 12(5):523-8. PubMed ID: 2288707 [TBL] [Abstract][Full Text] [Related]
6. Established and experimental treatments for sickle cell disease. De Franceschi L; Corrocher R Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275 [TBL] [Abstract][Full Text] [Related]
7. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. Hebbel RP; Boogaerts MA; Eaton JW; Steinberg MH N Engl J Med; 1980 May; 302(18):992-5. PubMed ID: 7366623 [TBL] [Abstract][Full Text] [Related]
8. Erythrocyte/endothelial interactions and the vasocclusive severity of sickle cell disease. Hebbel RP; Eaton JW; Steinberg MH; White JG Prog Clin Biol Res; 1981; 55():145-62. PubMed ID: 7291188 [TBL] [Abstract][Full Text] [Related]
9. Calcium exchange and calcium-related effects in normal and sickle cell anemia erythrocytes. Cameron BF; Smariga P Prog Clin Biol Res; 1978; 20():105-22. PubMed ID: 148652 [TBL] [Abstract][Full Text] [Related]
10. Thrombosis and sickle cell disease. De Franceschi L; Cappellini MD; Olivieri O Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857 [TBL] [Abstract][Full Text] [Related]
12. Sickle erythrocytes adhere to endothelial cell monolayers (ECM's) exposed to flowing blood. Grabowski EF Prog Clin Biol Res; 1987; 240():167-79. PubMed ID: 3615485 [TBL] [Abstract][Full Text] [Related]
13. Denatured hemoglobin in sickle erythrocytes. Asakura T; Minakata K; Adachi K; Russell MO; Schwartz E J Clin Invest; 1977 Apr; 59(4):633-40. PubMed ID: 845254 [TBL] [Abstract][Full Text] [Related]
14. The possible role of red blood cell microvesicles in atherosclerosis. Blum A Eur J Intern Med; 2009 Mar; 20(2):101-5. PubMed ID: 19327596 [TBL] [Abstract][Full Text] [Related]
15. Abnormal vesiculation and calcium transport by 'one-step' inside-out vesicles from sickle cell anemia red cells. Comparisons with transport by intact cells. Bookchin RM; Raventos C; Lew VL Prog Clin Biol Res; 1981; 55():163-82. PubMed ID: 7291189 [No Abstract] [Full Text] [Related]
16. Extracorpuscular factors in the pathogenesis of sickle cell disease. Hebbel RP Am J Pediatr Hematol Oncol; 1982; 4(3):316-9. PubMed ID: 7149170 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiologically based drug treatment of sickle cell disease. Steinberg MH Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854 [TBL] [Abstract][Full Text] [Related]